Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization.

Floriana BonuraSimona De GraziaCelestino BonuraGiuseppa L SanfilippoGiovanni M GiammancoEmanuele AmodioDonatella Ferraro

Published in: Journal of applied microbiology (2022)

This study highlights the kinetics and the persistence of Nt-Abs in HCWs vaccinated with Comirnaty (BNT162b2) Pfizer-BioNTech, and compared the Nt-Abs levels with anti-SARS-CoV-2 S1/S2 IgGs titres during a 4-month follow-up starting at the first dose of vaccine.

Keyphrases

sars cov
respiratory syndrome coronavirus
dengue virus
amino acid
binding protein